FILING RADAR

Connecting to SEC EDGAR… Pricing Sign in

← All filings

QNRX

Quoin Pharmaceuticals Ltd. SEC filings

Pharmaceutical Preparations · Nasdaq · Incorporated in Israel

On the radar right now · 1

Nov 6, 5:18 PM ET

Quoin Pharmaceuticals Ltd.QNRX

Earnings results

Filing history

2026-11-06

Current report 8-K

Earnings results

2026-11-05

Quarterly report 10-Q

2026-11-04

EFFECT EFFECT

2026-11-04

Current report 8-K

Material agreement

2026-11-04

Prospectus 424B5

2026-11-04

Prospectus 424B5

2026-10-28

Shelf registration (future share sales) S-3

2026-10-26

Insider trade (amended) 4/A

2026-10-20

Current report 8-K

Reg FD disclosureOther event

2026-10-14

Current report 8-K

Reg FD disclosureOther event

2026-10-07

Passive 5%+ stake update SCHEDULE 13G/A

2026-10-02

Proxy statement (shareholder vote) DEF 14A

2026-09-25

EFFECT EFFECT

2026-09-25

Prospectus 424B3

2026-09-22

PRE 14A PRE 14A

2026-09-22

Current report 8-K

Reg FD disclosureOther event

2026-09-18

Shelf registration (future share sales) S-3

2026-09-10

D D

Item 06b

2026-09-10

Current report 8-K

Reg FD disclosureOther event

2026-09-01

Insider trade 4

2026-09-01

Insider trade 4

2026-09-01

Insider trade 4

2026-09-01

Insider trade 4

2026-08-28

Insider trade 4

2026-08-28

Insider trade 4

2026-08-28

Current report 8-K

Material agreementShare sale (dilution)Reg FD disclosureOther event

2026-08-20

Current report 8-K

Exec/director changeShareholder voteOther event

2026-08-14

Current report 8-K

Earnings results

2026-08-14

Quarterly report 10-Q

2026-07-16

Annual report to shareholders ARS

2026-07-16

Proxy statement (shareholder vote) DEF 14A

2026-07-06

PRE 14A PRE 14A

2026-06-23

Current report 8-K

Reg FD disclosureOther event

2026-06-04

Current report 8-K

Reg FD disclosureOther event

2026-06-02

Passive 5%+ stake SCHEDULE 13G

2026-06-02

Prospectus 424B3

2026-05-15

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-15

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-15

Passive 5%+ stake update SCHEDULE 13G/A

2026-05-07

Current report 8-K

Earnings results